SARS-CoV-2 re-infection: development of an epidemiological definition from India

被引:27
|
作者
Mukherjee, Aparna [1 ]
Anand, Tanu [1 ]
Agarwal, Anup [1 ]
Singh, Harpreet [2 ]
Chatterjee, Pranab [3 ]
Narayan, Jitendra [1 ]
Rana, Salaj [1 ]
Gupta, Nivedita [1 ]
Bhargava, Balram [4 ]
Panda, Samiran [1 ]
机构
[1] ICMR Headquarters, Div Epidemiol & Communicable Dis, Delhi, India
[2] ICMR Headquarters, Div Informat Syst & Res Management, Delhi, India
[3] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[4] ICMR Headquarters, Delhi, India
关键词
COVID-19; re-infection; viable virus; viral shedding;
D O I
10.1017/S0950268821000662
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The current investigation was conducted with the objective to develop an epidemiological case definition of possible severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection and assess its magnitude in India. The epidemiological case definition for SARS-CoV-2 re-infection was developed from literature review of data on viral kinetics. For achieving second objective, the individuals who satisfied the developed case definition for SARS-CoV-2 re-infection were contacted telephonically. Taking available evidence into consideration, re-infection with SARS-CoV-2 in our study was defined as any individual who tested positive for SARS-CoV-2 on two separate occasions by either molecular tests or rapid antigen test at an interval of at least 102 days with one negative molecular test in between. In this archive based, telephonic survey, 58 out of 1300 individuals (4.5%) fulfilled the above-mentioned definition; 38 individuals could be contacted with healthcare workers (HCWs) accounting for 31.6% of the cases. A large proportion of participants was asymptomatic and had higher Ct value during the first episode. While SARS-CoV-2 re-infection is still a rare phenomenon, there is a need for epidemiological definition of re-infection for establishing surveillance systems and this study contributes to such a goal. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection is an emerging concern and there is a need to define it. Therefore, working epidemiological case definition for re-infection was developed and its magnitude was explored via archive-based, telephonic survey. Re-infection with SARS-CoV-2 was defined as two positive tests at an interval of at least 102 days with one interim negative test. Thirty-eight of the 58 eligible patients could be contacted with 12 (31.6%) being HCWs. Majority of the participants were asymptomatic and had higher Ct value during their first episode. To conclude, a working epidemiological case definition of SARS-CoV-2 re-infection is important to strengthen surveillance. The present investigation contributes to this goal and records reinfection in 4.5% of SARS-CoV-2 infected individuals in India.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Possible Re-infection with SARS-CoV-2 in a Splenectomized Patient from Kocaeli, Turkey
    Toygar Deniz, Muge
    Akhan, Sila
    Esgin, Melih Berkay
    Sayan, Murat
    Argun Baris, Serap
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2021, 10
  • [2] Re-infection of SARS-CoV-2: A case in a young dental healthcare worker
    Fageeh, Hytham
    Alshehri, Abdulrahman
    Fageeh, Hammam
    Bizzoca, Maria E.
    Lo Muzio, Lorenzo
    Quadri, Mir F. A.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (06) : 685 - 688
  • [3] SARS-CoV-2 re-infection versus prolonged shedding: A case series
    Nicholson, Erin G.
    Avadhanula, Vasanthi
    Fragoso, Sonia
    Stroh, Rachel
    Ye, Xunyan
    Bond, Nanette
    Santarcangelo, Patricia
    Stroh, John
    Piedra, Pedro A.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (06) : 691 - 696
  • [4] Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran
    Mostafa Salehi-Vaziri
    Tahmineh Jalali
    Behrokh Farahmand
    Fatemeh Fotouhi
    Mohammad Banifazl
    Mohammad Hassan Pouriayevali
    Mona Sadat Larijani
    Neda Afzali
    Amitis Ramezani
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 1713 - 1719
  • [5] Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran
    Salehi-Vaziri, Mostafa
    Jalali, Tahmineh
    Farahmand, Behrokh
    Fotouhi, Fatemeh
    Banifazl, Mohammad
    Pouriayevali, Mohammad Hassan
    Sadat Larijani, Mona
    Afzali, Neda
    Ramezani, Amitis
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (08) : 1713 - 1719
  • [6] Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
    Field, C. J.
    Heinly, T. A.
    Patel, D. R.
    Sim, D. G.
    Luley, E.
    Gupta, S. L.
    Vanderford, T. H.
    Wrammert, J.
    Sutton, T. C.
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 1103 - 1114
  • [7] Distinguishing SARS-CoV-2 bonafide re-infection from pre-existing minor variant reactivation
    Siqueira, Juliana D.
    Goes, Livia R.
    Alves, Brunna M.
    da Silva, Ana Carla P.
    de Carvalho, Pedro S.
    Cicala, Claudia
    Arthos, James
    Viola, Joao P. B.
    Soares, Marcelo A.
    INFECTION GENETICS AND EVOLUTION, 2021, 90
  • [8] Re-infection with a different SARS-CoV-2 clade and prolonged viral shedding in a hematopoietic stem cell transplantation patient
    Alshukairi, Abeer N.
    El-Kafrawy, Sherif A.
    Dada, Ashraf
    Yasir, Muhammad
    Yamani, Amani H.
    Saeedi, Mohammed F.
    Aljohaney, Ahmed
    AlJohani, Naif, I
    Bahaudden, Husam A.
    Alam, Intikhab
    Gojobori, Takashi
    Radovanovic, Aleksandar
    Alandijany, Thamir A.
    Othman, Norah A.
    Alsubhi, Tagreed L.
    Hassan, Ahmed M.
    Tolah, Ahmed M.
    Al-Tawfiq, Jaffar A.
    Zumla, Alimuddin
    Azhar, Esam, I
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 110 : 267 - 271
  • [9] Modelling the dynamics of infection, waning of immunity and re-infection with the Omicron variant of SARS-CoV-2 in Aotearoa New Zealand
    Vattiatio, Giorgia
    Lustig, Audrey
    Maclaren, Oliver J.
    Plank, Michael J.
    EPIDEMICS, 2022, 41
  • [10] A case with SARS-CoV-2 reinfection from India
    Munivenkatappa, Ashok
    Sahay, Rima R.
    Deshpande, Gururaj R.
    Patil, Deepak Y.
    Shete, Anita M.
    Sapkal, Gajanan N.
    Kumar, Ravish
    Narayana, Marappa
    Yadav, Pragya D.
    Shettar, Vijay
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2022, 40 (01) : 166 - 168